ARS Pharmaceuticals

In launching epinephrine nasal spray, ARS Pharma has a 'blue sky opportunity,' analyst says
Fierce Pharma
Wed, 08/21/24 - 10:37 pm
ARS Pharmaceuticals
Neffy
drug launches
epinephrine nasal spray
FDA approves nasal spray alternative to EpiPen for allergic reactions
Reuters
Sun, 08/11/24 - 01:07 pm
FDA
ARS Pharmaceuticals
allergic reactions
anaphylaxis
EpiPen
Neffy
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
BioSpace
Sun, 09/24/23 - 08:52 pm
FDA
ARS Pharmaceuticals
Novartis
Taysha
Alvotech
Intarcia
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
Forbes
Wed, 09/20/23 - 08:30 am
ARS Pharmaceuticals
FDA
epinephrine nasal spray
Neffy
allergic reactions
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative
CBS News
Thu, 05/11/23 - 08:57 pm
ARS Pharmaceuticals
FDA
epinephrine nasal spray
Neffy
Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative
Geekwire
Fri, 07/22/22 - 10:07 am
Silverback Therapeutics
M&A
ARS Pharmaceuticals